Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.03 - $0.09 $7 - $22
250 New
250 $0
Q4 2022

Feb 13, 2023

BUY
$0.18 - $0.3 $45 - $75
250 New
250 $0
Q3 2021

Nov 05, 2021

SELL
$1.53 - $1.85 $382 - $462
-250 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$1.55 - $2.15 $387 - $537
250 New
250 $0
Q1 2021

May 24, 2021

SELL
$1.99 - $2.9 $497 - $725
-250 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$2.69 - $4.95 $672 - $1,237
250 New
250 $1,000
Q2 2020

Aug 10, 2020

SELL
$0.7 - $4.16 $175 - $1,040
-250 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$0.62 - $3.6 $155 - $900
250 New
250 $0

Others Institutions Holding NAVB

About NAVIDEA BIOPHARMACEUTICALS, INC.


  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.